Renin-angiotensin system at the interface of COVID-19 infection
Author:
Funder
National Plan for Science, Technology and Innovation
King Abdulaziz City for Science and Technology
Publisher
Elsevier BV
Subject
Pharmacology
Reference133 articles.
1. Counter-regulatory 'renin-angiotensin' system-based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-infected patients;Annweiler;Infect. Disord. - Drug Targets,2020
2. The Angiotensin-converting enzyme inhibitor captopril inhibits poly(adp-ribose) polymerase activation and exerts beneficial effects in an ovine model of burn and smoke injury;Asmussen;Shock,2011
3. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites;Belouzard;Proc. Natl. Acad. Sci. U. S. A.,2009
4. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults;Bunyavanich;Jama,2020
5. Myocardial infarction increases ACE2 expression in rat and humans;Burrell;Eur. Heart J.,2005
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients;Diabetology International;2024-07-26
2. Human Lung Mast Cells as a Possible Reservoir for Coronavirus: A Novel Unrecognized Mechanism for SARS-CoV-2 Immune-Mediated Pathology;International Journal of Molecular Sciences;2024-06-13
3. Correlation between anti-hypertensive drugs and disease progression among moderate, severe, and critically ill COVID-19 patients in the second referral hospital in Surabaya: A retrospective cohort study;F1000Research;2023-07-21
4. Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years;JMIRx Med;2023-01-20
5. T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes;Journal of Clinical Medicine;2023-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3